Neopterin Is a Cerebrospinal Fluid Marker for Treatment Outcome Evaluation in Patients Affected by Trypanosoma brucei gambiense Sleeping Sickness

Update on field use of the available drugs for the chemotherapy of human African trypanosomiasis

(2012) P. P. SIMARRO et al.   PARASITOLOGY

Cerebrospinal Fluid Neopterin as Marker of the Meningo-Encephalitic Stage of Trypanosoma brucei gambiense Sleeping Sickness

(2012) Natalia Tiberti et al.   PLoS One

Early Prediction of Treatment Efficacy in Second-Stage Gambiense Human African Trypanosomiasis

(2012) Gerardo Priotto et al.   PLoS Neglected Tropical Diseases

pROC: an open-source package for R and S+ to analyze and compare ROC curves

(2011) Xavier Robin et al.   BMC BIOINFORMATICS

Sleeping sickness

(2011) D. Malvy et al.   CLINICAL MICROBIOLOGY AND INFECTION

Diagnostic Accuracy of PCR in gambiense Sleeping Sickness Diagnosis, Staging and Post-Treatment Follow-Up: A 2-year Longitudinal Study

(2011) Stijn Deborggraeve et al.   PLoS Neglected Tropical Diseases

The Human African Trypanosomiasis Control and Surveillance Programme of the World Health Organization 2000–2009: The Way Forward

(2011) Pere P. Simarro et al.   PLoS Neglected Tropical Diseases

Identification of Stage Biomarkers for Human African Trypanosomiasis

(2010) Daniel Ndem Amin et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

How to Shorten Patient Follow‐Up after Treatment forTrypanosoma brucei gambienseSleeping Sickness

(2010) Dieudonné Mumba Ngoyi et al.   JOURNAL OF INFECTIOUS DISEASES

Discovery and Verification of Osteopontin and Beta-2-microglobulin as Promising Markers for Staging Human African Trypanosomiasis

(2010) Natalia Tiberti et al.   MOLECULAR & CELLULAR PROTEOMICS

Matrix metalloproteinase-9 and intercellular adhesion molecule 1 are powerful staging markers for human African trypanosomiasis

(2010) Alexandre Hainard et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection

(2010) Lars Hagberg et al.   AIDS Research and Therapy

Expression and Role of CXCL10 during the Encephalitic Stage of Experimental and Clinical African Trypanosomiasis

(2009) Daniel N. Amin et al.   JOURNAL OF INFECTIOUS DISEASES

African trypanosome infections of the nervous system: Parasite entry and effects on sleep and synaptic functions

(2009) Krister Kristensson et al.   PROGRESS IN NEUROBIOLOGY

Comparison of operational criteria for treatment outcome ingambiensehuman African trypanosomiasis

(2009) D. Mumba Ngoyi et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Increased CXCL-13 levels in human African trypanosomiasis meningo-encephalitis

(2009) Bertrand Courtioux et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Immunospecific immunoglobulins and IL-10 as markers forTrypanosoma brucei rhodesienselate stage disease in experimentally infected vervet monkeys

(2009) M. Ngotho et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

A Combined CXCL10, CXCL8 and H-FABP Panel for the Staging of Human African Trypanosomiasis Patients

(2009) Alexandre Hainard et al.   PLoS Neglected Tropical Diseases

The continuing problem of human African trypanosomiasis (sleeping sickness)

(2008) Peter G. E. Kennedy   ANNALS OF NEUROLOGY

Novel Markers for Treatment Outcome in Late‐StageTrypanosoma brucei gambienseTrypanosomiasis

(2008) Veerle Lejon et al.   CLINICAL INFECTIOUS DISEASES

Diagnosing central nervous system trypanosomiasis: two stage or not to stage?

(2008) Peter G.E. Kennedy   TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE